Ted Knous
Direttore/Membro del Consiglio presso University of Kansas
Posizioni attive di Ted Knous
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Kansas | Direttore/Membro del Consiglio | 31/03/2009 | - |
Storia della carriera di Ted Knous
Precedenti posizioni note di Ted Knous
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Igxbio, Inc.
 Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Direttore/Membro del Consiglio | 31/03/2009 | - |
Formazione di Ted Knous
| University of Minnesota | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Igxbio, Inc.
Igxbio, Inc. Pharmaceuticals: MajorHealth Technology Igxbio, Inc. develops DNA immunotherapies for HIV infection. It offers GenePro, a DNA therapeutic incorporating a DNA composition that yields high levels of gene expression and non-infectious HIV protein production, and induces an antibody and cellular immune response in animal models, including non-human primates. The company was founded in 2002 and is headquartered in Fairway, KS. | Health Technology |
- Borsa valori
- Insiders
- Ted Knous
- Esperienza
